首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
ISSN：0160-2446

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

J CARDIOVASC PHARM
学科领域：医学
是否预警：不在预警名单内
是否OA：否
录用周期：平均1月
新锐分区：医学4区
年发文量：124
影响因子：2.2
JCR分区：Q2

基本信息

《心血管药理学杂志》是一本同行评审的多学科杂志，发表关于心血管药理学基础和临床方面的原创文章和相关综述文章。期刊鼓励提交心血管药理学/医学的所有方面，包括但不限于：中风、肾病、脂质紊乱、糖尿病、全身性和肺动脉高血压、癌症血管生成、循环的神经和激素控制、脓毒症、具有血管成分的神经变性疾病、心脏和血管重塑、心力衰竭、绞痛、抗凝剂/抗血小板剂、影响血管平滑肌的药物/试剂和心律失常。药物作用的生理学和药理学基础、代谢、药物相互作用和副作用、应用药物以获得对生理学或病理学状况的新见解、新的和已确立的药剂的临床结果以及新方法。重点是药理学在其最广泛的应用，不仅纳入传统的方法，但新的方法，以发展药剂和预防和治疗心血管疾病。请注意，JCVP不发表基于混合和不确定化学成分或未知浓度的生物浸提物的工作。
0160-2446SCIE/Scopus收录
2.2
点击查看最新影响趋势>
2.3
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学4区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
4区
PHARMACOLOGY & PHARMACY 药学
4区
否
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：CARDIAC & CARDIOVASCULAR SYSTEMS
SCIE
Q2
111/231
学科：PHARMACOLOGY & PHARMACY
SCIE
Q3
209/352
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：CARDIAC & CARDIOVASCULAR SYSTEMS
SCIE
Q3
119/231
学科：PHARMACOLOGY & PHARMACY
SCIE
Q3
207/353
91
124
点击查看年发文量趋势图>
31%约97.5%平均1月-医学-心血管系统
4.5%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
74.19%16.87%1.64%
CiteScore：5.30
SJR：0.684
SNIP：0.554
学科类别分区排名百分位
大类：Medicine
小类：Cardiology and Cardiovascular Medicine
Q2
109 / 397
大类：Medicine
小类：Pharmacology
Q2
132 / 321

期刊高被引文献

Cell-Specific Roles of NLRP3 Inflammasome in Myocardial Infarction.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/FJC.0000000000000709
The role of Caspase 1 in ischemia/reperfusion injury of the myocardium.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/FJC.0000000000000694
Inhibition of Endothelial Dysfunction by Dietary Flavonoids and Preventive Effects Against Cardiovascular Disease.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/fjc.0000000000000757
NLRP3 inflammasome in cardioprotective signaling.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/FJC.0000000000000696
ALDH2 Activation Inhibited Cardiac Fibroblast-to-Myofibroblast Transformation Via the TGF-&bgr;1/Smad Signaling Pathway
来源期刊：Journal of Cardiovascular PharmacologyDOI：10.1097/FJC.0000000000000655
cGMP Signaling and Modulation in Heart Failure.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/FJC.0000000000000749
Atorvastatin Improves Doxorubicin-Induced Cardiac Dysfunction by Modulating Hsp70, Akt, and MAPK Signaling Pathways
来源期刊：Journal of Cardiovascular PharmacologyDOI：10.1097/FJC.0000000000000646
Alirocumab in Acute Myocardial Infarction: Results from the Virginia Commonwealth University Alirocumab Response Trial (VCU-AlirocRT).
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/FJC.0000000000000706
Potential of the Cardiovascular Drug Levosimendan in the Management of Amyotrophic Lateral Sclerosis: An Overview of a Working Hypothesis.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/fjc.0000000000000728
Cyclodextrin Ameliorates the Progression of Atherosclerosis via Increasing High-Density Lipoprotein Cholesterol Plasma Levels and Anti-inflammatory Effects in Rabbits
来源期刊：Journal of Cardiovascular PharmacologyDOI：10.1097/FJC.0000000000000660
Chrysin Alleviates Chronic Hypoxia-Induced Pulmonary Hypertension by Reducing Intracellular Calcium Concentration in Pulmonary Arterial Smooth Muscle Cells.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/fjc.0000000000000726
Comparison of Candesartan and Angiotensin-(1-7) Combination to Mito-TEMPO Treatment for Normalizing Blood Pressure and Sympathovagal Balance in (mREN2)27 Rats
来源期刊：Journal of Cardiovascular PharmacologyDOI：10.1097/FJC.0000000000000645
A Novel and Highly Potent Urotensin II Receptor Antagonist Inhibits Urotensin II–Induced Pressure Response in Mice
来源期刊：Journal of Cardiovascular PharmacologyDOI：10.1097/FJC.0000000000000618
Efficacy of Minimally Invasive Intervention in Patients With Acute Cerebral Infarction
来源期刊：Journal of Cardiovascular PharmacologyDOI：10.1097/FJC.0000000000000625
Efficacy and Safety of Loading Doses With P2Y12-Receptor Antagonists in Patients Without Dual Antiplatelet Therapy Undergoing Elective Coronary Intervention
来源期刊：Journal of Cardiovascular PharmacologyDOI：10.1097/FJC.0000000000000632
Circulating Mesencephalic Astrocyte-derived Neurotrophic Factor Negatively Correlates with Atrial Apoptosis in Human Chronic Atrial Fibrillation.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/FJC.0000000000000781
Xanthoangelol prevents ox-LDL-induced endothelial cell injury by activating Nrf2/ARE signaling.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/FJC.0000000000000699
Antihypertrophic Effects of Nebivolol on Neonatal Cardiomyocyte Hypertrophy Models
来源期刊：Journal of Cardiovascular PharmacologyDOI：10.1097/FJC.0000000000000647
Real-Life Indications to Sacubitril/Valsartan Treatment in Patients With Chronic Systolic Heart Failure
来源期刊：Journal of Cardiovascular PharmacologyDOI：10.1097/FJC.0000000000000665
Mechanism of Emulsified Isoflurane Postconditioning–Induced Activation of the Nrf2–Antioxidant Response Element Signaling Pathway During Myocardial Ischemia-Reperfusion: The Relationship With Reactive Oxygen Species
来源期刊：Journal of Cardiovascular PharmacologyDOI：10.1097/FJC.0000000000000668
Erythropoietin improves cardiovascular function in adult rats after acute hemorrhage.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/FJC.0000000000000666
Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/FJC.0000000000000697
CYP17A1 Polymorphisms are Linked to the Risk of Coronary Heart Disease in A Case-control Study.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/FJC.0000000000000687
Effects of oral anticoagulants on ≥90-year-old atrial fibrillation patients: comparison among direct oral anticoagulant, warfarin anticoagulant, and non-anticoagulation.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/FJC.0000000000000703
Successful COMPASS, disappointing COMMANDER HF, what have we learned from these two trials?
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/FJC.0000000000000712
Should we judge stroke risk by static or dynamic risk scores? A focus on the dynamic nature of stroke and bleeding risks in patients with atrial fibrillation.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/FJC.0000000000000750
Upregulating MicroRNA-203 Alleviates Myocardial Remodeling and Cell Apoptosis Through Downregulating Protein Tyrosine Phosphatase 1B in Rats With Myocardial Infarction.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/FJC.0000000000000733
Inhibition of TRPA1 Promotes Cardiac Repair in Mice after Myocardial Infarction.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/FJC.0000000000000783
Ginsenoside Rb1 alleviates ox-LDL-induced vascular endothelium senescence via the SIRT1/Beclin-1/autophagy axis.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/FJC.0000000000000775
The pharmacodynamic effects of a dopamine-somatostatin chimera agonist on the cardiovascular system.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/FJC.0000000000000695
Effects of Low-Dose Sacubitril/Valsartan on Different Stages of Cardiac Hypertrophy in Salt-Loaded Hypertensive Rats
来源期刊：Journal of Cardiovascular PharmacologyDOI：10.1097/FJC.0000000000000662
CD137-CD137L signaling affects angiogenesis by mediating phenotypic conversion of macrophages.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/fjc.0000000000000772
In Vitro Anticoagulant Activity of Mikania laevigata: Deepening the Study of the Possible Interaction Between Guaco and Anticoagulants.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/fjc.0000000000000745
Roles of Endothelin B Receptors and Endothelial Nitric Oxide Synthase in the Regulation of Pulmonary Hemodynamic in Cirrhotic Rats
来源期刊：Journal of Cardiovascular PharmacologyDOI：10.1097/FJC.0000000000000650
Nitric oxide in post-cardiac arrest syndrome.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/fjc.0000000000000765
DOCA/Salt: much more than a model of hypertension.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/FJC.0000000000000753
FSTL3 Induces Lipid Accumulation and Inflammatory Response in Macrophages and Associates With Atherosclerosis.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/fjc.0000000000000742
Perivascular adipose tissue modulation of neurogenic vasorelaxation of rat mesenteric arteries.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/FJC.0000000000000761
Long Noncoding RNA NEAT1 Promotes Myocardiocyte Apoptosis and Suppresses Proliferation Through Regulation of miR-129-5p.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/fjc.0000000000000741
Ginsenoside Re preserves cardiac function and ameliorates left ventricular remodeling in a rat model of myocardial infarction.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/FJC.0000000000000752
Effect of Intensive and Standard Lipid-Lowering Therapy on the Progression of Stroke in Patients With Coronary Artery Syndromes: A Meta-Analysis of Randomized Controlled Trials
来源期刊：Journal of Cardiovascular PharmacologyDOI：10.1097/FJC.0000000000000784
Role of NFATc1 in the bone-vascular axis calcification paradox.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/FJC.0000000000000788
Mild Hypothermia Is Ineffective to Protect Against Myocardial Injury Induced by Chemical Anoxia or Forced Calcium Overload
来源期刊：Journal of Cardiovascular PharmacologyDOI：10.1097/FJC.0000000000000639
Association of MMP-1 (rs1799750)-1607 2G/2G and MMP-3 (rs3025058)-1612 6A/6A genotypes with coronary artery disease risk among Iranian Turks.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/FJC.0000000000000727
Activation of Cannabinoid Receptors Attenuates Endothelin-1–Induced Mitochondrial Dysfunction in Rat Ventricular Myocytes
来源期刊：Journal of Cardiovascular PharmacologyDOI：10.1097/FJC.0000000000000758
Spatiotemporal Dynamics of Immune Cells in Early Left Venticular Remodeling after Acute Myocardial Infarction in Mice.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/FJC.0000000000000777
Atorvastatin Attenuates Cold-induced Hypertension by Preventing Gut Barrier Injury.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/FJC.0000000000000690
Patients With CONgestive Heart Failure Benefit From Long-Term Treatment Effects With Novel Treatment Using Azosemide Compared With Furosemide Derived From Existing Retrospective Study Data: CONTENTED.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/FJC.0000000000000669
Nebivolol improves obesity-induced vascular remodelling by suppressing NLRP3 activation.
来源期刊：Journal of cardiovascular pharmacologyDOI：10.1097/FJC.0000000000000667

相关文章

Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15
Neurobiology of Stress：中科院 2 区，认可度高，国人发文第二，机会公平
2025-10-15
NATURE REVIEWS DRUG DISCOVERY：中科院1区，生物工程与应用微生物，药学，接受率为21%
2025-10-15

期刊推荐

ACSMS HEALTH & FITNESS JOURNAL封面

ACSMS HEALTH & FITNESS JOURNAL

学科领域：医学
影响因子：1.8
中科院分区： 4区
ACTA BIOQUIMICA CLINICA LATINOAMERICANA封面

ACTA BIOQUIMICA CLINICA LATINOAMERICANA

学科领域：医学
影响因子：0.1
中科院分区： 4区
Acta Cardiologica Sinica封面

Acta Cardiologica Sinica

学科领域：医学
影响因子：1.8
中科院分区： 4区
Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca封面

Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca

学科领域：医学
影响因子：0.4
中科院分区： 4区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布（新锐分区）
大类学科小类学科Top期刊综述期刊
医学4区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
4区
PHARMACOLOGY & PHARMACY 药学
4区
否
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学4区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
4区
PHARMACOLOGY & PHARMACY 药学
4区
否
否
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学4区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
4区
PHARMACOLOGY & PHARMACY 药学
4区
否
否